Immunovant Inc

IMVT•United States

Healthcare United States Biological ProductsOptions Available

Need professional-grade analysis? Visit stockanalysis.com

$29.49

+4.28%

End of day

Market Cap

$5.22B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	12.23	21.87	1.30	4.36	3.24	0.30	4.75
Calmar	—	—	2.31	7.24	4.70	0.16	3.54
Sharpe	4.53	12.22	0.77	2.29	1.87	0.17	2.53
Omega	1.89	2.12	1.19	1.39	1.31	1.11	1.37
Martin	—	—	5.62	19.44	10.59	0.28	8.76
Ulcer	1.75	2.43	7.06	6.40	9.31	45.46	16.36

Immunovant Inc (IMVT) Price Performance

Immunovant Inc (IMVT) trades on United States in USD. The company is classified in the Healthcare sector under the Biological Products industry. The stock currently trades at $29.49, up 4.28% from the previous close.

Over the past year, IMVT has traded between a low of $13.78 and a high of $29.49. The stock has gained 104.1% over this period. It is currently 114.0% above its 52-week low.

Immunovant Inc has a market capitalization of $5.22B.

About Immunovant Inc

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Company Info

Sector: Healthcare
Industry: Biological Products
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): N/A
EBITDA: $-486,751,008
Profit Margin: N/A
EPS (TTM): -1.79
Book Value: 4.85

Technical Indicators

52 Week High: $29.55
52 Week Low: $13.36
50 Day MA: $26.09
200 Day MA: $21.41
Beta: 0.67

Valuation

Trailing P/E: N/A
Forward P/E: -9.78
Price/Sales: N/A
Price/Book: 5.29
Enterprise Value: $4.35B

Ratio

Score

Sortino

12.23

21.87

1.30

4.36

3.24

0.30

4.75

Calmar

—

2.31

7.24

4.70

0.16

3.54

Sharpe

4.53

12.22

0.77

2.29

1.87

0.17

2.53

Omega

1.89

2.12

1.19

1.39

1.31

1.11

1.37

Martin

—

5.62

19.44

10.59

0.28

8.76

Ulcer

1.75

2.43

7.06

6.40

9.31

45.46

16.36

Immunovant Inc (IMVT) Price Performance

Over the past year, IMVT has traded between a low of $13.78 and a high of $29.49. The stock has gained 104.1% over this period. It is currently 114.0% above its 52-week low.

Immunovant Inc has a market capitalization of $5.22B.

About Immunovant Inc

Immunovant Inc

Price Chart

Risk-Adjusted Performance

Immunovant Inc (IMVT) Price Performance

About Immunovant Inc

Company Info

Financial Metrics

Technical Indicators

Valuation

Immunovant Inc

Price Chart

Risk-Adjusted Performance

Immunovant Inc (IMVT) Price Performance

About Immunovant Inc

Company Info

Financial Metrics

Technical Indicators

Valuation

Compare Immunovant Inc